
Franchising
Our experienced franchising lawyers have a 360-degree view of the global franchising industry. We have decades of experience advising franchisors and master franchisees across a variety of industries. By leveraging our global platform, our legal team delivers a full range of services to companies doing business around the world.
Our representation of franchisors ranges from emerging systems to some of the largest franchisors in the world. We understand the issues and challenges that each of these franchise systems face. Clients recognize that we understand their business, have in-depth knowledge, and maintain an ability to provide counsel in major markets around the world where our clients conduct business.
Our legal service platform caters to every aspect of franchised businesses. We possess significant experience in all legal disciplines in which our franchise clients operate, including litigation and arbitration, compliance, corporate governance, and information security and data privacy. Our lawyers also provide counsel on commercial contracts, restructuring and insolvency, employment law, government relations, mergers and acquisitions, and public company operations. We have substantial experience with franchise disclosure documents, franchise agreements, franchise registration laws, franchise relationship laws, and global distribution platforms, including a franchising team that has been established in Australia for the past three decades.
Members of our franchise team are frequent authors and speakers at top hospitality and franchise industry events hosted by the International Franchise Association, American Bar Association Forum on Franchising, and the American Hotel and Lodging Association, as well as numerous bar association, corporate counsel, and trade organization groups.
We have substantial experience handling a broad spectrum of matters related to franchising, including:
- Commercial, cross-border, and international transactions
- Cybersecurity, data protection, and data privacy
- Intellectual property
- Corporate matters
- Mergers and acquisition
- Commercial litigation
- Real estate
- Insurance recovery and counseling
- Restructuring and insolvency
- Employment law
- Financial services
- Government relations
- Advertising, marketing, sweepstakes, and promotions
- Immigration
Thought Leadership
On February 28, 2019, the staff of the Division of Investment Management of the U.S.
On 23 December 2020, Judge Catherine Blake of the U.S. District Court for the District of Maryland granted the Pharmaceutical Research and Manufacturers of America (PhRMA) a 14-day nationwide temporary restraining order, preventing the Centers for Medicare and Medicaid Services (CMS) from implementing and enforcing its Most Favored Nation (MFN) interim final rule (MFN Rule) scheduled to take effect on 1 January 2021.
Following earlier announcements as to the efficacy of vaccine trials by pharmaceutical companies Pfizer, Inc. (Pfizer) and Moderna, Inc. on November 20, 2020, Pfizer and BioNTech submitted applications for emergency use authorization to the U.S. Food and Drug Administration (FDA) for their COVID-19 vaccinations.
This alert provides a brief overview of the final rules and the potential policy tools available to the Biden administration should it seek to revisit them.